$IKT
Inhibikase Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.30
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInhibikase Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IKT up today? It is at $2.30 (+0.00%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IKT spikes, and full due diligence on IKT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IKT 17 times in the last 30 days. Create a free account to track $IKT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KRegulation FD DisclosureSep 8, 2026 · 11 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Berman Dennis N Director | Other | 22K 0.02% of company | n/a | 22K | $28K at $1.26 | Jul 30, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -18.03M 12.9% of company | sold 72% | 6.97M | n/a | Jul 29, 26 |
Munshi Amit Director | Sold (automatic/other) | -19K 0.01% of company | sold 33% | 38K | n/a | Feb 21, 26 |
Cabell Christopher Officer | Sold (automatic/other) | -338K 0.2% of company | sold 33% | 677K | n/a | Feb 21, 26 |
Aurentz Vincent Director | Sold (automatic/other) | -255K 0.2% of company | sold 33% | 511K | n/a | Feb 21, 26 |
Sands Capital Life Sciences Pulse Fund Ii, L.P. Beneficial Owner (10%) | Bought (open market) | +2.07M 1.5% of company | added 19% | 13.02M | $3.0M at $1.45 | Nov 21, 25 |
Munshi Amit Director | Acquired (grant/award) | +57K 0.04% of company | n/a | 57K | n/a | Feb 21, 25 |
Munshi Amit Director | Bought (open market) | +365K 0.3% of company | n/a | 365K | $500K at $1.37 | Oct 21, 24 |
Kush Arvind Director | Bought (open market) | +145K 0.1% of company | n/a | 145K | $199K at $1.37 | Oct 21, 24 |
Bellini Roberto Director | Bought (open market) | +1.46M 1.0% of company | n/a | 1.46M | $2.0M at $1.37 | Oct 21, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on IKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IKT last traded at $2.30, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The IKT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IKT 17 times in the last 30 days.
IKT (Inhibikase Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $321M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IKT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IKT discussion
Sign in to ask a question or join the discussion.